Rare actinomycetes: a potential storehouse for novel antibiotics

Abstract

New antimicrobial agents are desperately needed to combat the increasing number of antibiotic resistant strains of pathogenic microorganisms. Natural products remain the most propitious source of novel antibiotics. It is widely accepted that actinobacteria are prolific producers of natural bioactive compounds. We argue that the likelihood of discovering a new compound having a novel chemical structure can be increased with intensive efforts in isolating and screening rare genera of microorganisms. Screening rare actinomycetes and their previously under-represented genera from unexplored environments in natural product screening collections is one way of achieving this. Rare actinomycetes are usually regarded as the actinomycete strains whose isolation frequency is much lower than that of the streptomycete strains isolated by conventional methods. Many natural environments are still either unexplored or under-explored and thus, can be considered as a prolific resource for the isolation of less exploited microorganisms. More and different ecological niches need to be studied as sources of a greater diversity of novel microorganisms. In this review, we wish to update our understanding of the potential of the rare actinomycetes by focusing on the ways and means of enhancing their bio-discovery potential.

Keywords::

• Rare actinomycetes
• antibiotics
• Actinomadura
• Actinoplanes
• Dactylosporangium
• Kibdelosporangium
• Microbispora
• Micromonospora
• Salinospora
• Streptosporangium
• Verrucosispora

Acknowledgments

We are very grateful to Prof. Hans-Peter Fiedler, Department of Microbiology/Biotechnology, University of Tübingen, Germany for his thorough revision of this review and providing us with his invaluable suggestions.

Declaration of interest

We acknowledge the financial support from MOEF and AICTE (8023/RID/NPROJ/RPS-38/2008-9).